Biotech

All Articles

OS Therapies refiles $6M IPO to fund HER2 medication, preclinical ADCs

.OS Therapies will definitely list on the NYSE American sell substitution today using a $6.4 million...

ALX's waning CD47 action rate sends out supply spiraling down

.ALX Oncology's phase 2 stomach cancer reaction price has actually weakened. After seeing its own CD...

Ionis axes eye disease from targets of Roche-partnered possibility after information disappoint

.Yet Another of Ionis Pharmaceuticals' key midphase readouts has fallen short of requirements, causi...

Biogen's chief executive officer pointed out no dangerous handle 2023. He's ready to be daring

.While Biogen's pharma peers are searching for late-stage properties along with little bit of threat...

Instil refills pipeline in $2B biobucks manage ImmunOnco

.Instil Biography has actually been a biotech searching for a pipe after it ditched its own lead ass...

Biogen bows out Denali Alzheimer's collab

.Biogen has handed back civil rights to a very early Alzheimer's ailment program to Denali Therapies...

Takeda taps new mind people oncology business-- Chutes &amp Ladders

.Accept to recently's Chutes &amp Ladders, our roundup of notable leadership hirings, shootings and ...

Vertex, beaten by AATD once more, drops 2 possessions on throw away stack

.Tip's attempt to address an uncommon genetic disease has struck an additional drawback. The biotech...

Vir increases 3 T-cell engagers coming from Sanofi, gives up 25% of staff

.Vir Biotechnology's second-quarter incomes file wasn't except large information. The provider accep...

Galapagos stops CAR-T cell therapy hearing over Parkinsonism situation

.Galapagos has stopped enrollment in a test of a BCMA-directed CAR-T cell therapy, pumping the brake...